Glimify-MV 1 Tablet
Prescription Required
Introduction of Glimify-MV Tablet
Glimify-MV 1 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glimify-MV 1 Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Glimify-MV 1 Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Uses of Glimify-MV Tablet
Benefits of Glimify-MV Tablet
In Treatment of Type 2 diabetes mellitus
Glimify-MV 1 Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Glimify-MV 1 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Glimify-MV 1 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Glimify-MV Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glimify-MV
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
How to use Glimify-MV Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimify-MV 1 Tablet is to be taken empty stomach.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Glimify-MV 1 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Glimify-MV 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Glimify-MV 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
UNSAFE
Glimify-MV 1 Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Use of Glimify-MV 1 Tablet is, however, not recommended in patients with severe kidney disease.
Use of Glimify-MV 1 Tablet is, however, not recommended in patients with severe kidney disease.
Liver
CAUTION
Glimify-MV 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimify-MV 1 Tablet may be needed. Please consult your doctor.
Glimify-MV 1 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Glimify-MV 1 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
What if you forget to take Glimify-MV Tablet?
If you miss a dose of Glimify-MV 1 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Glimify-MV 1 Tablet
₹12.0/Tablet
Tripride 1 HV Tablet
Micro Labs Ltd
₹12/tablet
same price
Switglim MV 1mg/500mg/0.3mg Tablet
Akumentis Healthcare Ltd
₹12.2/tablet
2% costlier
Trivoglicad 1 mg/500 mg/0.3 mg Tablet
Cadomed Pharmaceuticals Pvt Ltd
₹9.15/tablet
24% cheaper
Vogic GM 1 Tablet
Carise Pharmaceuticals Pvt Ltd
₹10/tablet
17% cheaper
Glimpure MV 1.3 Tablet
Arrient Healthcare Pvt Ltd
₹11.8/tablet
2% cheaper
Quick tips
Glimify-MV Tablet
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
User feedback
Patients taking Glimify-MV 1 Tablet
Twice A Day
67%
Once A Day
33%
FAQs
Glimify-MV Tablet
What is Glimify-MV 1 Tablet?
Glimify-MV 1 Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
What are the possible side effects of Glimify-MV 1 Tablet?
The use of Glimify-MV 1 Tablet is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which Glimify-MV 1 Tablet should not be taken?
The use of Glimify-MV 1 Tablet should be avoided in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine is also avoided in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimify-MV 1 Tablet?
No, it is not safe to take Glimify-MV 1 Tablet along with alcohol. It may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Can the use of Glimify-MV 1 Tablet cause hypoglycemia?
Yes, the use of Glimify-MV 1 Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of blood sugar level is important. Always keep glucose tablets, honey or fruit juice with you.
What are the instructions for the storage and disposal of Glimify-MV 1 Tablet?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Glimepiride. Bridgewater, New Jersey: Sanofi-Aventis U.S. LLC.; 2009. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. [Accessed 08 Apr. 2019] (online) Available from:
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from:
- Glimepiride+Metformin+Voglibose [Product Monograph]. Punjab, India: Centaur Pharmaceuticals Pvt. Ltd.; 2018. [Accessed 25 Oct. 2021] (online) Available from:
Marketer details
Name: Fidus Healthcare
Address: P. NO. 33 SHRI KRISHNA NAGAR, PATRAKAR COLONY MANSAROVAR EXTENSION JAIPUR Jaipur RJ 302020 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
68 people viewed this recentlyMRP
₹120
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT